Table 1.
Clinical and epidemiological characteristics of patients with COVID-19 infection from Chuchunco health center.
| Parameters analyzed | 1st wave | Inter-wave | 2nd wave | Docima | |
|---|---|---|---|---|---|
| Patients (number) | Total | 666 | 323 | 705 | |
| Gender (number) | Women | 355 | 183 | 365 | |
| Men | 311 | 140 | 340 | X2 = 2.1; P > 0.05 | |
| Average Age | 47.5 ± 17 | 44.9 ± 17 | 42.7 ± 16 | F = 13.4; P <0.05 | |
| Symptomatology (%) | Asymptomatic | 8.0 | 9.3 | 5.2 | |
| Symptomatic | 92.0 | 90.7 | 94.8 | X2 = 6.7; P <0.05 | |
| Survival rate (%) | Recovery | 95.5 | 98.5 | 99.4 | |
| Mortality | 4.5 | 1.5 | 0.6 | X2 = 24.6; P <0.05 | |
| Duration of symptoms (days; mean ± SD) | 17.5 ± 13 | 11.6 ± 12 | 11.5 ± 7 | F = 74.2; P <0.05 | |
| Viral load (copies/μl) | 1,15 x 107 ± 5,37 x 107 | 1,73 x 106 ± 7,0 x 106 | 4,56 x 105 ± 2,64 x 106 | F = 236.8; P <0.05 | |
| Comorbidity (%) | Presence | 42.8 | 37.2 | 30.0 | |
| Absence | 57.2 | 62.8 | 70.0 | X2 = 24.4; P <0.05 | |
| Type of comorbidities (%) | Arterial hypertension (AHT) | 28.4 | 33.2 | 33.0 | |
| Type 2 diabetes (T2D) | 17.9 | 17.9 | 18.7 | ||
| Dyslipidemia (DL) | 10.1 | 2.6 | 9.8 | ||
| Obesity | 10.1 | 2.6 | 1.3 | ||
| Mental disorder (MD) | 2.3 | 12.7 | 2.4 | ||
| Hypothyroidism (HT) | 4.5 | 2.2 | 4.7 | ||
| Acute myocardial infarction (AMI) | 2.3 | 2.6 | 7.1 | ||
| Pulmonary fibrosis (PF) | 0.3 | 0.4 | 11.1 | ||
| Asthma (AS) | 4.6 | 3,5 | 1.6 | ||
| Insulin resistance (RI) | 3.0 | 5.2 | 1.1 | ||
| Chronic kidney disease (CKD) | 3.3 | 0.4 | 2.9 | ||
| Chronic obstructive pulmonary disease (COPD) | 2.1 | 1.3 | 0.8 | ||
| Heart failure (HF) | 1.5 | 2.6 | 1.1 | ||
| Epilepsy (EP) | 1.0 | 4.4 | 0.8 | ||
| Dementia (DM) | 2.1 | 0.4 | 0.5 | ||
| Cardiovascular accident (CA) | 1.7 | 0.9 | 1.1 | ||
| Valvulopathy (VA) | 0.5 | 0.9 | 1.3 | ||
| Rheumatoid arthritis (RA) | 0.8 | 1.7 | 0.0 | ||
| Atrial fibrillation (AF) | 1.2 | 0.4 | 0.0 | ||
| Inflammatory bowel disease (ABD) | 0.3 | 2.6 | 0.0 | ||
| Fibromyalgia (FB) | 0.5 | 0.4 | 0.3 | ||
| Tuberculosis (TBC) | 0.5 | 0.0 | 0.0 | ||
| Chronic liver damage (CLD) | 0.3 | 0.0 | 0.3 | ||
| Down's Syndrome (DS) | 0.2 | 0.9 | 0.0 | ||
| Celiac Disease (CD) | 0.3 | 0.0 | 0.0 | ||
| Myasthenia gravis (MG) | 0.2 | 0.0 | 0.0 | ||
| Parkinson's | 0.0 | 0.0 | 0.3 | X2 = 136.4; P <0.05 | |